Category: Epilepsy
Epilepsy market research reports by DelveInsight
-
Developmental and Epileptic Encephalopathies (DEE) - Market Insight, Epidemiology And Market Forecast - 2034
Developmental and Epileptic Encephalopathies (DEE) - Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The total market size of congenital adrenal hyperplasia in 2023 was more than USD 20 million in the 7MM, which is expected to grow at a CAGR of ~40% during the forecast period ... Read More
-
Developmental and Epileptic Encephalopathies (DEE) - Epidemiology Forecast - 2034
Developmental and Epileptic Encephalopathies (DEE) - Epidemiology Forecast - 2034 Key Highlights In 2020, the total diagnosed prevalent cases of DEE in the US were ~141,310 In 2023, the diagnosed prevalent cases of Lennox Gastaut Syndrome in the US were ~50,090. In 2023, the total diagnosed prevalen ... Read More
-
Drug Resistant Epilepsy – Market Insight, Epidemiology, and Market Forecast – 2034
Drug Resistant Epilepsy – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Drug Resistant Epilepsy – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Drug Resistant Epilepsy, historical and forecasted epidemiology a ... Read More
-
KCNQ2 Developmental and Epileptic Encephalopathy (KCNQ2-DEE) – Market Insight, Epidemiology, and Market Forecast – 2034
KCNQ2 Developmental and Epileptic Encephalopathy (KCNQ2-DEE) – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""KCNQ2 Developmental and Epileptic Encephalopathy (KCNQ2-DEE) – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understandin ... Read More
-
Partial Epilepsy – Market Insight, Epidemiology, and Market Forecast – 2034
Partial Epilepsy – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Partial Epilepsy – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Partial Epilepsy, historical and forecasted epidemiology as well as the Partial ... Read More
-
Refractory Epilepsy – Market Insight, Epidemiology, and Market Forecast – 2034
Refractory Epilepsy – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Refractory Epilepsy – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Refractory Epilepsy, historical and forecasted epidemiology as well as th ... Read More
-
Dravet Syndrome – Market Insight, Epidemiology, and Market Forecast – 2034
Dravet Syndrome – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Dravet Syndrome – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Dravet Syndrome, historical and forecasted epidemiology as well as the Dravet Syn ... Read More
-
Chronic Focal Epilepsy – Market Insight, Epidemiology, and Market Forecast – 2034
Chronic Focal Epilepsy – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Chronic Focal Epilepsy – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Chronic Focal Epilepsy, historical and forecasted epidemiology as w ... Read More
-
Anti-Epileptic Drugs/Epilepsy - Pipeline Insight, 2024
Anti-Epileptic Drugs/Epilepsy - Pipeline Insight, 2024 Anti-Epileptic Drugs/Epilepsy Overview ""Anti-Epileptic Drugs/Epilepsy Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Anti-Epileptic Drugs/E ... Read More
-
Vagus Nerve Stimulator (VNS) - Market Insights, Competitive Landscape and Market Forecast-2027
Vagus Nerve Stimulator (VNS) - Market Insights, Competitive Landscape and Market Forecast-2027 Vagus Nerve Stimulators Market By Product Type (Invasive VNS Devices And Non-Invasive VNS Devices), By Application (Migraine, Epilepsy, Depression, And Others), By End User (Hospitals, Specialty Clinics, A ... Read More
-
Drug Resistant Epilepsy - Pipeline Insight, 2022
Drug Resistant Epilepsy - Pipeline Insight, 2022 DelveInsight’s, Drug Resistant Epilepsy - Pipeline Insight, 2022,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Drug Resistant Epilepsy pipeline landscape. It covers the pipeline drug profiles, including clinica ... Read More
-
Refractory Epilepsy - Epidemiology Forecast to 2032
DelveInsight's "" Refractory Epilepsy - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Refractory Epilepsy epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. G ... Read More
-
Drug Resistant Epilepsy - Epidemiology Forecast to 2032
DelveInsight's "" Drug Resistant Epilepsy - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Drug Resistant Epilepsy epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and ... Read More
-
Partial Epilepsy - Epidemiology Forecast to 2032
DelveInsight's "" Partial Epilepsy - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Partial Epilepsy epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geograp ... Read More
-
Anti-Epileptic Drugs/Epilepsy - Epidemiology Forecast - 2032
DelveInsight's "" Anti-Epileptic Drugs/Epilepsy - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Anti-Epileptic Drugs/Epilepsy epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Ki ... Read More
-
Drug-Resistant refractory epilepsy - Epidemiology Forecast - 2032
DelveInsight's "" Drug-Resistant refractory epilepsy - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Drug-Resistant refractory epilepsy epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the ... Read More
-
Epilepsy - Epidemiology Forecast to 2032
DelveInsight's "" Epilepsy - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Epilepsy epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • T ... Read More
-
Parkinson's Disease Treatment Resistant Epilepsy - Epidemiology Forecast - 2032
DelveInsight's "" Parkinson's Disease Treatment Resistant Epilepsy - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Parkinson's Disease Treatment Resistant Epilepsy epidemiology in the 7MM, i.e., the United States, EU5 (Germany, S ... Read More
-
Developmental and Epileptic Encephalopathies (DEE) - Epidemiology Forecast to 2032
DelveInsight's "" Developmental and Epileptic Encephalopathies (DEE) - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Developmental and Epileptic Encephalopathies (DEE) epidemiology in the 7MM, i.e., the United States, EU5 (German ... Read More
-
Lennox Gastaut Syndrome - Epidemiology Forecast to 2032
DelveInsight's "" Lennox Gastaut Syndrome - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Lennox Gastaut Syndrome epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and ... Read More
Research Assistance
